Advertisement

Topics

Achillion Company Profile

05:30 EST 15th December 2018 | BioPortfolio

Achillion is an innovative pharmaceutical company dedicated to bringing important new treatments to patients with infectious disease. The Company’s discovery and development teams have advanced multiple product candidates with novel mechanisms of action. Achillion is focused on solutions for the most challenging problems in infectious disease — HIV, hepatitis and resistant bacterial infections. Achillion’s drug development pipeline is led by elvucitabine (Beta-L-Fd4C or ACH-126,443), which is currently in late-stage Phase 2 clinical trials for the treatment of patients infected with HIV. Achillion’s candidate for the potential treatment of HCV infection, ACH-806, is in a Phase 1 clinical trial and is anticipated to be completed by the first half of 2006.

Location

300 George Street
New Haven,
Connecticut
06511
United States of America

Contact

Phone: 203-624-7000
Fax: 203-624-7003
Email: info@achillion.com


News Articles [28 Associated News Articles listed on BioPortfolio]

Achillion’s C3G trial earmarked for success, despite slow recruitment

Complement glomerulopathy (C3G) is an ultrarare kidney disease with no specific approved drugs, though physicians use steroids and mycophenolate to...Read More... The post Achillion’s C3G trial earm...

Achillion Pharmaceuticals, Inc. Strategy, SWOT and Corporate Finance Report [Report Updated: 15102018] Prices from USD $175

Achillion Pharmaceuticals, Inc. Strategy, SWOT and Corporate Finance ReportSummaryAchillion Pharmaceuticals, Inc. Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company da...

Achillion Pharma Appoints Steven Zelenkofske Chief Medical Officer

Steven Zelenkofske has joined Achillion Pharmaceuticals (NASDAQ: ACHN) as executive vice president and chief medical officer of the New Haven, CT, drug developer. Zelenkofske most recently worked at u...

Management tracks: Achillion, Navidea

Achillion Is A Worthwhile Biotech Speculation

Achillion Reports Third Quarter 2018 Financial Results

- Completed enrollment of Phase 2 clinical trial of ACH-4471 in PNH as monotherapy -- Interim data and strategic update planned for December 17, 2018 –- September 30, 2018 cash & securities pos...

Achillion Reports Second Quarter 2018 Financial Results

- Global phase 2 clinical programs for ACH-4471 continue to expand in PNH and C3G -- Completed dosing phase 1 clinical study of ACH-5228 and initiated phase 1 study of ACH-5548 -- June 30, 2018 cash ...

Achillion Pharmaceuticals - Biotech Gold For The Price Of Dirt

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [2 Associated Clinical Trials listed on BioPortfolio]

Safety and Antiviral Study of ACH-126, 443 (Beta-L-Fd4C) in the Treatment of Adults With Chronic Hepatitis B Infection.

The purpose of this study is to determine the safety and antiviral HBV activity of ACH-126,443 (beta-L-Fd4C) in the treatment of Subjects of Previous Achillion-Sponsored Phase 1 and 2 Stud...

Study of Once Daily Elvucitabine Versus Lamivudine in Subjects With a Documented M184V Mutation

HIV-1 infected patients receiving long-term therapy with lamivudine or emtricitabine (nucleoside reverse transcriptase inhibitors [NRTIs]) are at risk for the development of a mutation at ...

Companies [2 Associated Companies listed on BioPortfolio]

Achillion

Achillion is an innovative pharmaceutical company dedicated to bringing important new treatments to patients with infectious disease. The Company’s discovery and development teams have advanced mult...

Achillion Pharmaceuticals

Achillion is a privately held pharmaceutical company focused on the discovery, development and commercialization of innovative small molecule drugs that combat drug resistance in infectious diseases, ...

More Information about "Achillion" on BioPortfolio

We have published hundreds of Achillion news stories on BioPortfolio along with dozens of Achillion Clinical Trials and PubMed Articles about Achillion for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Achillion Companies in our database. You can also find out about relevant Achillion Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Infectious-diseases
Antiretroviral Therapy Clostridium Difficile Ebola HIV & AIDS Infectious Diseases Influenza Malaria Measles Sepsis Swine Flu Tropical Medicine Tuberculosis Infectious diseases are caused by pathogenic...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...


Corporate Database Quicklinks



Searches Linking to this Company Record